|Home | Speakers | Agenda | Venue | Delegates | Sponsors | Media | Register|
As part of our successful Genomic series of events, the Synthetic Biology Congress was held on October 20-21 in London, UK. It was co-located with our qPCR and Digital PCR Congress.
The combined events attracted over 400 attendees and more than 50 poster presentations. The Synthetic Biology streams examined the latest strategies, developments and case studies using synthetic biology to further research in healthcare and the agriculture sectors. The congress also had a dedicated section focusing on finance, aimed at those looking for investment opportunities and those seeking funding to exploit their research.
News and updates on the 2015 Congress will be released after the new year.
See feedback from the meeting:
Predicted to be worth $10.8bn globally in 2016, synthetic biology is a fast-growing research area making tremendous scientific, technological and economical impacts worldwide. The conference therefore provided a timely interactive networking forum offering the opportunity to take home cutting edge research, strategies, methods and solutions to allow you to keep up to date with the latest advancements, novel methods and applications of Synthetic Biology within your field.
The Congress offered a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations and interactive Q&A panel discussions from a 40 strong speaker faculty examining topics on:
Healthcare / Drug Discovery
Plant Synthetic Biology
Investment, Funding and Bioethics
For a more detailed synopsis and the full agenda from the last meeting, please visit the Agenda Page
|© Global Engage 2014|